The Valley Desk

ReviewClinical lymphoma, myeloma & leukemiaPublished

Real-World Evidence on Ibrutinib in First-Line Chronic Lymphocytic Leukemia/ Small Lymphocytic Lymphoma: A Comprehensive Review

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

Publication record

Type
Review
Venue
Clinical lymphoma, myeloma & leukemia
Published
Subject terms
Humans; Piperidines; Adenine; Protein Kinase Inhibitors; Leukemia, Lymphocytic, Chronic, B-Cell; Effectiveness; Outcomes; Btk Inhibitor; Cll/sll; Dose Adjustments
PubMed ID
41529988
Added to directory
Source checked

Report a correction or request removal